Case study: Digital spatial profiling of metastatic clear cell carcinoma reveals intra-tumor heterogeneity in epithelial-mesenchymal gradient

Duncan Yi-Te Wang, Tuan Zea Tan, Ya-Ting Tai, Jieru Ye, Wei‐Chou Lin, Lin‐Hung Wei, Ruby Yun‐Ju HuangbioRxiv 2021 · DOI

TL;DR

This study uses advanced digital spatial profiling to reveal a previously uncharacterized epithelial-mesenchymal (EM) gradient within metastatic ovarian clear cell carcinoma (OCCC) tumors. This gradient, absent in primary tumors, suggests a dynamic shift in cell states during cancer progression, offering new insights for precision medicine.

What Problem Does This Paper Address?

Intra-tumor heterogeneity (ITH) is a known driver of poor outcomes in many cancers, including ovarian clear cell carcinoma (OCCC). While ITH is recognized, its specific manifestations and spatial organization within OCCC, particularly the epithelial-mesenchymal (EM) transition, remain poorly understood. Traditional methods often lose the crucial spatial context of these cellular changes. This paper aims to address this gap by using a cutting-edge technology to spatially map protein expression within OCCC tumors, specifically looking for evidence of an EM gradient and its implications for cancer progression.

Methods

The core technique employed is NanoString Digital Spatial Profiling (DSP) GeoMx platform. This method allows for multiplex protein expression analysis directly within tissue samples, preserving spatial information. The workflow involves:

  • Sample Preparation: Formalin-fixed, paraffin-embedded (FFPE) tissue sections from both primary and metastatic OCCC sites were used.
  • Visualization and Segmentation: Tissues were stained with markers for DNA, tumor cells (PanCK), and immune cells (CD45). Regions of Interest (ROIs) were selected and segmented based on H&E morphology and fluorescence signals.
  • Multiplex Protein Profiling: A specialized panel (18-plex Nanostring Immune Cell Profiling Core) was used to measure the expression of multiple proteins simultaneously within the defined segments.
  • Data Analysis: Readouts were normalized, and unsupervised hierarchical clustering was performed to identify distinct cell populations and their spatial relationships. Geospatial analysis was used to correlate protein expression with distance from the tumor core.

The novelty lies in the application of DSP to OCCC for detailed spatial mapping of ITH, specifically focusing on the EM gradient.

Datasets

The study utilized tumor samples from a single advanced ovarian clear cell carcinoma (OCCC) patient, including both primary ovarian tumor tissue and metastatic colonic tumor tissue. No new benchmark datasets were introduced.

Key Insights and Ideas

  • EM Gradient in Metastasis, Not Primary: A clear epithelial-mesenchymal (EM) gradient was observed in the metastatic tumor but was absent in the primary tumor. This suggests that the EM transition is a dynamic process that occurs during metastasis.
  • Spatial Organization of EM States: The EM gradient in the metastatic tumor showed a distinct pattern from the periphery to the core, with different hybrid EM states identified. This spatial organization is crucial for understanding how cancer cells adapt and spread.
  • Intermediate/Hybrid EM States: The study provides the first spatially resolved evidence of intermediate or hybrid EM states within OCCC tumors. These states are not purely epithelial or mesenchymal but represent transitional forms.
  • Hypoxia as a Potential Driver: The authors speculate that hypoxia within the tumor microenvironment may drive these EM changes, a phenomenon observed in other cancers.
  • DSP's Power for Precision Medicine: The findings highlight the significant potential of spatial profiling technologies like DSP for unraveling complex tumor biology and advancing precision medicine approaches.

Key Results

  • Differential Protein Expression: The metastatic tumor exhibited differential expression patterns of key proteins like PanCK, fibronectin (FN), smooth muscle actin (SMA), neural cell adhesion molecule (NCAM), integrin alpha X (ITGAX), and Ki-67, which were organized in a gradient.
  • Epithelial-like vs. Mesenchymal-like Cells: Primary tumor cells were generally more epithelial-like and homogenous, while metastatic cells were less epithelial and more heterogeneous, with lower PanCK and higher SMA expression.
  • Spatial Correlation: Geospatial analysis confirmed a significant correlation between protein expression (e.g., PanCK, SMA, FN, NCAM) and the distance from the tumor core in the metastatic samples. For instance, PanCK and SMA expression increased with distance from the core, while FN and NCAM decreased.
  • Subcluster Identification: PanCK-positive segments were categorized into two main clusters (C1_tumor and C2_tumor), with further subdivisions based on Ki-67 expression (C1_tumor_Ki-67high and C1_tumor_Ki-67low), representing different hybrid EM states.

Limitations and Future Work

  • Single Patient Study: The study is based on a single patient, which limits the generalizability of the findings. Future work should involve larger cohorts to validate these observations.
  • Technical Limitations of DSP: The authors acknowledge that DSP has limitations, such as the inability to analyze the entire tissue section and potential mis-labeling of erythrocytes as target cells in certain conditions.
  • Hypoxia Speculation: While hypoxia is speculated as a driver of EM changes, direct experimental validation was not performed in this study.
  • Future Directions: The authors suggest further investigation into the mechanisms driving these EM gradients, particularly the role of hypoxia, and exploring the clinical implications of these findings for treatment strategies. They also emphasize the need for appropriate study design to fully leverage the power of high-throughput multiplex platforms like DSP.

Summary updated

Abstract

Abstract Intrinsic intra-tumor heterogeneity (ITH) has been linked to worse patient outcomes. The development of spatial profiling technology has enabled the deciphering of ITH with multiple analysis readouts. Advanced ovarian clear cell carcinoma (OCCC), known to harbor ITH, is chemoresistant, poor prognostic, and possesses distinct molecular and histological characteristics. However, detailed spatial information of the nature of ITH within OCCC remains unclear. Here, we utilized the NanoString Digital spatial profiling (DSP) GeoMx platform to perform multiplex protein expression analysis on tumor samples of primary and colonic metastatic sites from one advanced OCCC patient. The spatial resolution revealed the existence of an epithelial-mesenchymal (EM) gradient within the metastatic tumor but not the primary tumor, and similar EM gradient was not observed within the primary tumor. The EM gradient exhibited a distinct pattern from the periphery to the core of the metastatic tumor. Compared to tumor cells at the primary site, there was an intermediate zone in between the tumor periphery and the tumor core in the colonic metastasis with differential expression patterns of pan-cytokeratin (PanCK), fibronectin (FN), smooth muscle actin (SMA), neural cell adhesion molecule (NCAM), integrin alpha X (ITGAX), and Ki-67. Our study provides the first spatially resolved in situ evidence of intermediate or hybrid EM states within the tumor samples of similar morphology. This not only demonstrates the promising applications of spatial profiling in precision medicine but also provides an unprecedented view of the EM gradient during the progression of cancer such as OCCC.
BibTeX
@misc{wang2021case,
  author = {Duncan Yi-Te Wang and Tuan Zea Tan and Ya-Ting Tai and Jieru Ye and Wei‐Chou Lin and Lin‐Hung Wei and Ruby Yun‐Ju Huang},
  title = {{Case study: Digital spatial profiling of metastatic clear cell carcinoma reveals intra-tumor heterogeneity in epithelial-mesenchymal gradient}},
  year = {2021},
  doi = {10.1101/2021.05.27.445912},
  howpublished = {bioRxiv},
}
Figure